Forty percent of participants studied by Zhou et al., had evidence of retinopathy or nephropathy and all were receiving either oral hypoglycaemic treatments or insulin treatment.[27] It is feasible that hypoglycaemic treatments may have contributed to the observed discrepancies in the relationship between circulating glucose and ABCG1 expression. The gene discussed is ABCG1; the disease is kidney disorder.